US Patent

US8841278 — Antiviral compounds

Method of Use · Assigned to Gilead Pharmasset LLC · Expires 2030-05-12 · 4y remaining

Vulnerability score 68/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects antiviral compounds, compositions containing them, and therapeutic methods for their administration, as well as processes and intermediates for preparing these compounds.

USPTO Abstract

The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

CodeDescriptionDrug
U-1470
U-1470
U-1470
U-1470

Patent Metadata

Patent number
US8841278
Jurisdiction
US
Classification
Method of Use
Expires
2030-05-12
Drug substance claim
No
Drug product claim
Yes
Assignee
Gilead Pharmasset LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.